Never miss a trade again with the fastest news alerts in the world!
 This headline only article is a sample of real-time intelligence
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Benzinga Pro</a> traders use to win in the markets everyday.
 Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters?
 <a href="https://benzinga.grsm.io/headlineonlyarticles3398">Join 10,000+ serious traders in the Benzinga Pro community!</a>

Biotech

News

Health Care

General

Athira Pharma Announced That A Symposium Presentation Highlighting Data From Preclinical Studies Of ATH-1105 For Amyotrophic Lateral Sclerosis Will Be Delivered At The Upcoming Motor Neurone Disease Association International Symposium - Athira Pharma (NASDAQ:ATHA)

Benzinga Newsdesk

Athira Pharma

ATHA

Athira Pharma Announced That A Symposium Presentation Highlighting Data From Preclinical Studies Of ATH-1105 For Amyotrophic Lateral Sclerosis Will Be Delivered At The Upcoming Motor Neurone Disease Association International Symposium

Comments